EW

SELL

Edwards Lifesciences Corporatio

Healthcare · Rank #148 · Analyzed Oct 18, 2026

$86.60

Current Price

$31.23

Intrinsic Value

-63.9%

Upside/Downside

3.5/10

Score

3.5/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score3.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 63.9%

Fair Value Range

Low$10.33

Base (IV)$31.23

High$37.57

Entry Points

Conservative$7.23

Moderate$10.33

Aggressive$21.86

Quality & Moat Breakdown

Return on Equity9.2% → 0/1.0

Debt LevelD/E 7 → 1.0/1.0

Revenue QualityGrowth 19.4%, margin Δ-32.0% +recovery → 1.0/1.0

Moat Strength3.0/5 → 0.5/1.0

Profit Margins15.4% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.